An Open Protocol for the Compassionate Use of Trametinib
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 18 Sep 2015
At a glance
- Drugs Trametinib (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 08 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 10 Feb 2015 New trial record
- 09 Feb 2015 Study objective and patient inclusion criteria changed to include the segment ''the development of tumors is associated with pathological skin disease mutation V600E or V600K'', as reported by ClinicalTrials.gov record.